https://pharmadog.xyz/news/505439 pharmadog en 2026-10-06T20:26:16.000Z Utah expands AI prescribing sandbox to boost health‑tech innovation https://pharmadog.xyz/news/505163 pharmadog en 2026-10-06T19:00:20.000Z Secretive new issue links diverse groups, raises concerns for pharma industry https://pharmadog.xyz/news/505059 pharmadog en 2026-10-06T18:04:00.000Z Forbion raises $2.6 billion for two European biotech venture funds https://pharmadog.xyz/news/504723 pharmadog en 2026-10-06T16:12:00.000Z ArriVent shares tumble as lung cancer trial of furmonertinib misses primary goal https://pharmadog.xyz/news/134233 pharmadog en 2026-10-06T15:49:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/504555 pharmadog en 2026-10-06T15:42:00.000Z AbbVie/Genmab’s Epkinly halves progression risk in frontline DLBCL trial https://pharmadog.xyz/news/504491 pharmadog en 2026-10-06T15:28:00.000Z AstraZeneca opens 570,000-sq-ft R&D campus in Cambridge, targeting 2,000 staff https://pharmadog.xyz/news/504323 pharmadog en 2026-10-06T14:47:37.000Z ArriVent's lead lung cancer drug firmonertinib fails Phase 3 trial, shares plunge https://pharmadog.xyz/news/504367 pharmadog en 2026-10-06T14:41:00.000Z AstraZeneca launches $1 billion R&D hub in Boston’s Kendall Square https://pharmadog.xyz/news/504368 pharmadog en 2026-10-06T14:30:00.000Z Trump proposes $90 monthly aid for seniors as stem cell therapies gain attention https://pharmadog.xyz/news/504970 pharmadog en 2026-10-06T14:21:00.000Z Nuvig Therapeutics pauses CIDP trial of NVG-2089, cites enrollment and cost challenges https://pharmadog.xyz/news/504369 pharmadog en 2026-10-06T14:13:12.000Z Hospitals Launch Cash‑Pay Longevity Clinics, Offering Intensive Health Monitoring https://pharmadog.xyz/news/504350 pharmadog en 2026-10-06T14:10:59.000Z Epkinly shows 51% PFS boost in frontline DLBCL, may become new standard of care https://pharmadog.xyz/news/504111 pharmadog en 2026-10-06T13:59:08.000Z FDA outlines roadmap for AI guidance to be released in 2027 https://pharmadog.xyz/news/504112 pharmadog en 2026-10-06T13:36:42.000Z U.S. government launches first federally funded ibogaine trials for opioid addiction and PTSD https://pharmadog.xyz/news/504067 pharmadog en 2026-10-06T13:33:07.000Z KymaThera secures $80M Series B to advance oral PI3Kα inhibitor K-1728 as biotech peers raise funds and go public https://pharmadog.xyz/news/504091 pharmadog en 2026-10-06T13:11:22.000Z Compliance worries keep AI adoption in drug manufacturing low, survey finds https://pharmadog.xyz/news/503899 pharmadog en 2026-10-06T12:46:45.000Z Forbion raises €2.3 billion with Lilly backing, launches largest Dutch VC fund to back ~30 life-science firms https://pharmadog.xyz/news/503900 pharmadog en 2026-10-06T12:00:43.000Z AI investments in healthcare delivering returns faster than executives anticipated https://pharmadog.xyz/news/80789 pharmadog en 2026-10-06T12:00:00.000Z Season 2 of The Progress Profile podcast spotlights Alzheimer’s research and patient-centered trial design https://pharmadog.xyz/news/503795 pharmadog en 2026-10-06T12:00:00.000Z Key Biopharma Conferences to Watch in 2027 Highlight Industry Trends https://pharmadog.xyz/news/503775 pharmadog en 2026-10-06T11:36:10.000Z When to get your flu shot: key factors to consider https://pharmadog.xyz/news/503731 pharmadog en 2026-10-06T11:05:14.000Z AbbVie and Genmab's Epkinly succeeds in late-stage first-line DLBCL trial, challenging Roche's Polivy https://pharmadog.xyz/news/504467 pharmadog en 2026-10-06T10:51:00.000Z ArriVent’s phase 3 EGFR inhibitor trial misses primary endpoint, shares plunge 57% https://pharmadog.xyz/news/503627 pharmadog en 2026-10-06T10:38:00.000Z GE HealthCare to buy Sofie Biosciences for $945 million, boosting U.S. PET radiopharma capacity https://pharmadog.xyz/news/504042 pharmadog en 2026-10-06T08:59:00.000Z Kairos pushes prostate cancer drug ENV-105 into earlier treatment line after promising mid-phase data https://pharmadog.xyz/news/503272 pharmadog en 2026-10-06T08:30:00.000Z Doctor warns AI-driven documentation may boost hospital bills without improving care https://pharmadog.xyz/news/503274 pharmadog en 2026-10-06T08:30:00.000Z Nonprofit hospitals launch pricey longevity clinics offering personalized health assessments https://pharmadog.xyz/news/503273 pharmadog en 2026-10-06T08:30:00.000Z Experts warn FDA against approving Grail’s ineffective multicancer blood test https://pharmadog.xyz/news/503271 pharmadog en 2026-10-06T08:30:00.000Z Study finds pulse oximeters at Johns Hopkins shifted from overestimating to underestimating oxygen, with larger errors in patients of color https://pharmadog.xyz/news/503227 pharmadog en 2026-10-06T08:21:13.000Z Lycia Therapeutics files for IPO to fund antibody degrader platform https://pharmadog.xyz/news/504802 pharmadog en 2026-10-06T08:10:00.000Z Abbott receives FDA clearance for CardioMEMS HF System updates enabling home pressure monitoring via smartphone app https://pharmadog.xyz/news/503874 pharmadog en 2026-10-06T07:45:00.000Z Forbion raises record €2.3 billion to back 30 European biotech firms https://pharmadog.xyz/news/503370 pharmadog en 2026-10-06T05:09:00.000Z AstraZeneca opens 570,000-sq-ft Kendall Square R&D hub to boost cancer and biotech research https://pharmadog.xyz/news/502491 pharmadog en 2026-10-06T04:01:00.000Z BioSpace honors 40 emerging leaders shaping biopharma with breakthroughs in mRNA, gene and cell therapies https://pharmadog.xyz/news/503371 pharmadog en 2026-10-06T03:52:00.000Z TRex Bio targets $111M IPO as Retension and Lycia also prepare public listings https://pharmadog.xyz/news/503875 pharmadog en 2026-10-06T02:33:00.000Z UK regulator to shift from one-off checks to continuous monitoring of AI medical devices https://pharmadog.xyz/news/504466 pharmadog en 2026-10-05T21:10:00.000Z Mimetic Medicines' peptide reduces pain-related sodium channels in mice, offering new neuropathic pain strategy https://pharmadog.xyz/news/501059 pharmadog en 2026-10-05T20:13:42.000Z Federal Appeals Judges Reject HHS Arguments in Humana Medicare Advantage Audit Lawsuit https://pharmadog.xyz/news/501060 pharmadog en 2026-10-05T20:08:24.000Z Nobel-winning optogenetics opens path to experimental therapies for blindness and Alzheimer’s https://pharmadog.xyz/news/500847 pharmadog en 2026-10-05T19:40:45.000Z Leerink analyst downgrades Bristol Myers over pipeline concerns https://pharmadog.xyz/news/500679 pharmadog en 2026-10-05T18:58:14.000Z Genentech parts ways with global AI head Richard Bonneau https://pharmadog.xyz/news/500723 pharmadog en 2026-10-05T18:33:57.000Z Trump administration issues new rules to standardize health-insurance pricing disclosures https://pharmadog.xyz/news/500703 pharmadog en 2026-10-05T18:24:33.000Z Viking Therapeutics jumps 24% after Phase 1 obesity data, Longeveron falls 64% on mid-stage setback https://pharmadog.xyz/news/500279 pharmadog en 2026-10-05T16:38:08.000Z Staggering health insurance premiums force employers to rethink coverage options https://pharmadog.xyz/news/500235 pharmadog en 2026-10-05T16:27:02.000Z FDA delays review of Novo's hemophilia A drug denecimig over factory issues https://pharmadog.xyz/news/500111 pharmadog en 2026-10-05T16:00:14.000Z Utah moves forward with AI-driven acne prescription pilot, Nolla Health to test autonomous drug prescribing https://pharmadog.xyz/news/500299 pharmadog en 2026-10-05T15:57:00.000Z Shionogi to acquire Texas-based IntraBio for $2 billion, adding marketed rare-disease drug Aqneursa https://pharmadog.xyz/news/500091 pharmadog en 2026-10-05T15:16:04.000Z Two Massachusetts biotech firms shut down, ending cancer and eye‑disease programs https://pharmadog.xyz/news/500067 pharmadog en 2026-10-05T15:06:23.000Z Vaxcyte's experimental pneumococcal vaccine VAX-31 meets Phase 3 endpoints, shares jump 35% https://pharmadog.xyz/news/500068 pharmadog en 2026-10-05T15:02:14.000Z Genmab reports 45.9% response rate for FRα‑directed ADC in platinum‑resistant ovarian cancer; Lilly expands Jaypirca label https://pharmadog.xyz/news/500092 pharmadog en 2026-10-05T15:01:53.000Z Lilly adds $870M to Gate Bioscience partnership to pursue new drug targets https://pharmadog.xyz/news/499923 pharmadog en 2026-10-05T14:36:02.000Z Genentech signs up to develop Alector’s preclinical blood-brain barrier therapy in $1.27 billion deal https://pharmadog.xyz/news/499899 pharmadog en 2026-10-05T14:30:01.000Z Roche signs $100 million upfront deal with Alector to advance Parkinson's research https://pharmadog.xyz/news/499900 pharmadog en 2026-10-05T14:19:13.000Z Shionogi agrees $2 billion upfront purchase of IntraBio, adding oral rare-disease drug Aqneursa to its portfolio https://pharmadog.xyz/news/499901 pharmadog en 2026-10-05T14:00:22.000Z Report highlights 20 women reshaping biopharma across oncology and rare disease fields https://pharmadog.xyz/news/500131 pharmadog en 2026-10-05T13:57:00.000Z Nobel Prize honors optogenetics pioneers; Roche licenses Alector’s Parkinson’s enzyme therapy https://pharmadog.xyz/news/499775 pharmadog en 2026-10-05T13:55:41.000Z Eli Lilly's Jaypirca receives FDA approval for first-line treatment of untreated CLL and SLL https://pharmadog.xyz/news/499795 pharmadog en 2026-10-05T13:52:00.000Z Vaxcyte's next-gen pneumococcal vaccine matches leading shots in Phase 3 trial https://pharmadog.xyz/news/499755 pharmadog en 2026-10-05T13:32:51.000Z CSL strikes up to $1.6B deal with Alentis for autoimmune drug with broad potential https://pharmadog.xyz/news/499756 pharmadog en 2026-10-05T13:25:55.000Z Biogen's litifilimab shows clear or almost clear skin in cutaneous lupus after one year https://pharmadog.xyz/news/499757 pharmadog en 2026-10-05T13:23:59.000Z Vaxcyte’s VAX-31 shows superior results in Phase 3, beating Pfizer and Merck’s pneumococcal vaccines and sparking $8 bn market hopes https://pharmadog.xyz/news/499776 pharmadog en 2026-10-05T13:10:03.000Z Vaxcyte’s pneumococcal vaccine meets primary goals in Phase 3 trial, challenging Pfizer and Merck https://pharmadog.xyz/news/499982 pharmadog en 2026-10-05T13:02:06.000Z FDA issues request for information on early-phase ibogaine trial design https://pharmadog.xyz/news/499607 pharmadog en 2026-10-05T12:19:11.000Z Vaxcyte's experimental pneumococcal vaccine meets primary endpoints in Phase 3 trial https://pharmadog.xyz/news/499608 pharmadog en 2026-10-05T12:00:51.000Z 2026 Nobel Prize awarded to U.S. and German scientists for optogenetics breakthroughs https://pharmadog.xyz/news/499395 pharmadog en 2026-10-05T11:08:36.000Z Nobel prize honors scientists who pioneered light-activated gene therapy technology https://pharmadog.xyz/news/499396 pharmadog en 2026-10-05T11:00:27.000Z Sensible Bio raises $47 million Series A to build mRNA therapy manufacturing platform https://pharmadog.xyz/news/499397 pharmadog en 2026-10-05T11:00:22.000Z Epicrispr reports encouraging early data from EPI-321 in 12 patients with FSHD https://pharmadog.xyz/news/499874 pharmadog en 2026-10-05T10:09:00.000Z Genentech pays Alector $100M for preclinical Parkinson’s prospect https://pharmadog.xyz/news/499103 pharmadog en 2026-10-05T10:00:11.000Z 2026 Nobel Prize in Medicine awarded for optogenetics, the light-controlled brain research tool https://pharmadog.xyz/news/499015 pharmadog en 2026-10-05T09:00:00.000Z Diagnostic-driven therapies face patient loss due to workflow gaps, new commercialization model proposed https://pharmadog.xyz/news/499016 pharmadog en 2026-10-05T09:00:00.000Z AI drives faster drug development and reshapes biopharma manufacturing facilities https://pharmadog.xyz/news/498829 pharmadog en 2026-10-05T08:30:00.000Z Late-stage mRNA melanoma vaccine shows promise, slowing disease recurrence https://pharmadog.xyz/news/498827 pharmadog en 2026-10-05T08:30:00.000Z Stem cell advocates anticipate FDA roundtables as peptide therapies gain regulatory foothold https://pharmadog.xyz/news/498831 pharmadog en 2026-10-05T08:30:00.000Z Energy drinks partner with college sports, raising safety concerns for teens https://pharmadog.xyz/news/498828 pharmadog en 2026-10-05T08:30:00.000Z Will AI like Claude ever earn a Nobel Prize in medicine? https://pharmadog.xyz/news/498830 pharmadog en 2026-10-05T08:30:00.000Z Rising Hospital and Drug Prices Drive Up Insurance Premiums for Workers and Employers https://pharmadog.xyz/news/499538 pharmadog en 2026-10-05T08:16:00.000Z Vaxcyte’s 31-valent pneumococcal vaccine shows non-inferior immunity to Pfizer and Merck shots in Phase 3, shares surge https://pharmadog.xyz/news/499371 pharmadog en 2026-10-05T06:40:00.000Z Scientists awarded 2026 Nobel Prize for pioneering optogenetics light-switch technique https://pharmadog.xyz/news/498135 pharmadog en 2026-10-05T04:44:00.000Z Kyverna Therapeutics reports encouraging data for first CAR-T therapy targeting autoimmune disease https://pharmadog.xyz/news/499036 pharmadog en 2026-10-05T04:16:00.000Z CSL pays $355M upfront to co-develop Alentis’ phase-2 fibrosis drug lixudebart https://pharmadog.xyz/news/498759 pharmadog en 2026-10-05T04:15:00.000Z Genmab’s Rina-S ADC shows 9.5-month median PFS, touted as superior to AbbVie’s Elahere https://pharmadog.xyz/news/498136 pharmadog en 2026-10-05T04:03:00.000Z Roivant Sciences launches first solo drug, Lisraya, after FDA approval for dermatomyositis https://pharmadog.xyz/news/498137 pharmadog en 2026-10-05T04:02:00.000Z FDA urged to boost US access to new and experimental drugs as trials shift to China https://pharmadog.xyz/news/498138 pharmadog en 2026-10-05T04:01:00.000Z Swiss CDMOs and CROs experience rapid growth as global sponsors seek specialized manufacturing and decentralized trials https://pharmadog.xyz/news/500951 pharmadog en 2026-10-05T04:00:00.000Z BD and CareFusion recall Alaris Pump infusion sets due to serious performance risks https://pharmadog.xyz/news/500950 pharmadog en 2026-10-05T04:00:00.000Z ICU Medical updates IV tubing set instructions after reports of black specks in drip chambers https://pharmadog.xyz/news/497775 pharmadog en 2026-10-05T02:22:24.000Z CSL agrees $355M upfront deal to co-develop Alentis anti-fibrosis drug for kidney and liver https://pharmadog.xyz/news/499713 pharmadog en 2026-10-05T02:04:00.000Z FDA approves first expandable pediatric pulmonary heart valve https://pharmadog.xyz/news/501426 pharmadog en 2026-10-05T00:00:00.000Z FDA Requests Public Feedback on Designing Early-Phase Trials for Psychedelic Drug Ibogaine https://pharmadog.xyz/news/501425 pharmadog en 2026-10-05T00:00:00.000Z FDA warns Evolus over misleading Instagram claims about Jeuveau https://pharmadog.xyz/news/500922 pharmadog en 2026-10-05T00:00:00.000Z Bayer to invest $2.2B in new Ohio manufacturing complex as FDA CDER opens clinical trial modernization office https://pharmadog.xyz/news/500921 pharmadog en 2026-10-05T00:00:00.000Z Australia's TGA begins five-year transition to new medicine labeling standards